Pfizer begins pediatric trial of vaccine

WNYT Staff
Created: March 25, 2021 08:36 PM

Pfizer is launching a trial studying its vaccine in children aged six months to 11 years.

The first phase will test three different dosages of the vaccine.

Phases 2 and 3 will evaluate the vaccine's safety and effectiveness.

Pfizer says at the six-month follow-up visit, those who received the placebo will be given the opportunity to get the vaccine.

The vaccine is currently authorized for ages 16 and older.

Copyright 2021 - WNYT-TV, LLC A Hubbard Broadcasting Company